Skip to main content
Premium Trial:

Request an Annual Quote

DNAPrint, BioServe Team to Offer DNA Samples Tagged With Ancestral Data

NEW YORK (GenomeWeb News) — DNAPrint Genomics today said it has allied with BioServe to supply integrated clinical DNA samples tagged with genetic ancestral information to biomedical researchers.
 
Under the agreement, DNAPrint will use its genetic ancestry test to analyze and categorize BioServe’s Global Repository of nearly 600,000 human biological samples.
 
“With the added dimension of ancestry information to clinical samples, medical researchers will be able to determine whether certain biological markers are artifacts of genetic ancestry or are true markers for a disease or drug response in a disease,” the companies said in a joint statement.
 
DNAPrint CEO Richard Gabriel said that "by removing the question of ancestry from a clinical sample researchers can more readily evaluate which medicines will produce side effects within certain ethnic groups, and which medicines will work for the widest spectrum of a population.”
 
The agreement also allows the company to offer supportive services such as sample extraction and preparation, genotyping, and gene expression.
 
Financial terms of the deal were not released.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.